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from randomized controlled trials are
lacking. All of our patients had been
previously healthy, with no coexisting
conditions identified as poor prognos-
tic risk factors (2,10). These three
cases, together with the case of Wong
et al. (1), suggested that at least a sub-
set of SARS adult patients can have a
relatively benign clinical course and
uneventful recovery, without any spe-
cific treatment other than antimicro-
bial agents. 
Johnny W. M. Chan* 
and Samuel Lee*
*Queen Elizabeth Hospital, Hong Kong
Special Administrative Region, People’s
Republic of China
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Occupational
Malaria Following
Needlestick Injury
To the Editor: A 24-year-old
female nurse was admitted to the
emergency room at Bichat University
Hospital in Paris, France, on July 4,
2001, with fever, nausea, and general
malaise. She had no notable medical
history, except spontaneously regres-
sive Schönlein-Henloch purpura at 9
months of age. On admission, after
she was given paracetamol, her axil-
lary temperature was 37.6°C. She was
slightly jaundiced and reported a mild
headache but showed no resistance to
head flexion. Her abdomen was
depressible but tender. Urinalysis did
not show hematuria or signs of uri-
nary infection. Biologic tests indicat-
ed normal values except the follow-
ing: platelets 47.4 x 103/µL, aspartate
aminotransferase 307 U/L (normal
value <56), alanine aminotransferase
239 U/L (normal value <56), total
bilirubin 58 µmol/L (normal value
<24), and γ-glutamyl transpeptidase
57 U/L(normal value <35). Results of
an abdominal echogram were normal.
Result of a blood film to identify
Plasmodium falciparum was positive
for parasitemia at 0.038 per 100 ery-
throcytes. The patient was given 500
mg of oral quinine three times daily;
intravenous quinine was administered
15 hours after admission because she
became nauseated. Her malaise per-
sisted for 3 days, but she did not show
any signs of malaria. She recovered
completely and was discharged on
day 6 of hospitalization. 
The patient had not traveled out-
side France except to the United
Kingdom years earlier. She did not
live near an airport, nor had she been
to one recently. She had vacationed in
the south of France from June 23 to
June 26 but had traveled by car. She
had been certified as a registered
nurse on May 28 and had been work-
ing as a substitute employee at vari-
ous hospitals in the greater Paris area.
On June 21, 2001, she sustained an
accidental needlestick injury while
taking a blood sample with an
18-gauge, peripheral venous catheter
that had no safety feature. She
removed the catheter stylet and stuck
herself as she crossed her hands to
discard the stylet in a sharps contain-
er. The needlestick pierced the nurse’s
glove and caused a deep, blood-let-
ting injury on the anterior aspect of
the left wrist. She had no previous
history of needlestick injury. She
notified the hospital occupational
medicine department of her injury on
the day it occurred and was given a
postexposure interview. In accor-
dance with national postexposure
management guidelines, she was test-
ed for HIV and hepatitis C virus
(HCV) antibody, and results were
negative at baseline; her immuniza-
tion against hepatitis B virus (HBV)
was confirmed. The risk of infection
by pathogens other than HBV, HCV,
or HIV following a needlestick injury
was not discussed during her postex-
posure interview, and the nurse was
not made aware of that risk. The
injured nurse did not inform the man-
aging physician that the injury had
occurred while she was drawingLETTERS
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blood from a patient to determine if
the patient was infected with malaria.
By July 1, 10 days after exposure,
fatigue, malaise, and fever developed;
her temperature was lowered to
38.6°C by taking paracetamol. Her
condition returned to normal on July 2
before a second bout of fever and
myalgia occurred during the night.
She had to leave work early on July 3
because of generalized pain and a tem-
perature of 39°C. The patient’s mother
is a biologist and was aware that her
daughter had sustained a needlestick
injury while drawing blood from a
patient in whom malaria was suspect-
ed. The mother insisted that a blood
smear be performed at a private labo-
ratory in Paris. The smear was qualita-
tively determined positive for P. vivax.
Subsequently, the patient was admit-
ted to Bichat-Claude Bernard
University Hospital with suspected
malaria. A repeat blood smear con-
ducted there identified P. falciparum. 
The source patient was a 28-
weeks’ pregnant, 30-year-old woman
of Kenyan origin who resided in
France; she had visited Kenya and
returned to France on June 1, 2001. On
June 21, she was admitted to the gyne-
cology-obstetrics emergency room at a
greater Paris area hospital with fever
and malaise. Blood sampling and thin
and thick blood smears were per-
formed by the nurse. The source
patient’s level of parasitemia was esti-
mated at 0.05 per 100 erythrocytes,
and oral quinine was initiated. The
physician who interviewed the nurse
after the needlestick injury verified
that the source patient was HIV- and
HCV-antibody negative and that the
nurse was immunized against HBV.
On June 23, although the results of her
test for Plasmodium were negative,
she was transferred to another tertiary
care center where IV quinine was
administered for nausea and vomiting,
and she could be monitored more
closely. She recovered fully and was
discharged on June 27. Unfortunately,
all blood samples or smears from the
source patient had been discarded by
the time the injured nurse became ill. 
P. falciparum is a bloodborne
pathogen, and malaria is a well-docu-
mented complication of transfusion
(1). Malaria has also been diagnosed
after intravenous drug use (2,3) and
breaches in infection control proce-
dures (4–6), as well as occupational
exposures (1–5). Occupational P. fal-
ciparum infection after a needlestick
injury may be rare; however, such an
injury can be potentially severe in
nonimmune healthcare workers in
countries where malaria is not endem-
ic, especially if the occupationally
infected person is pregnant. This situ-
ation may also become more common
as malaria spreads and as increasing
international travel brings potential
source patients to hospitals in malar-
ia-endemic countries. 
HBV, HCV, and HIV are the
pathogens most often transmitted in
documented cases of occupational
infection following needlestick
injuries in industrialized countries.
Testing for infection by these
pathogens does not include all the
possible infections that can result
from occupational exposure (1,7,8).
Although conducting a thorough
investigation of the circumstances
surrounding any needlestick injury is
a challenge in the daily clinical set-
ting, an investigation should always
be carried out. As in this case-patient,
the treatment of occupational P. falci-
parum infection may be delayed
because physicians do not immediate-
ly consider malaria as a possible diag-
nosis. Furthermore, healthcare work-
ers with neurologic symptoms caused
by P. falciparum malaria may be too
ill to tell the treating physician about
their occupational exposure. Such
infections must be diagnosed prompt-
ly as they are potentially lethal, and
presumptive treatment is readily
available and well tolerated.
Clinicians managing healthcare or
laboratory workers with a febrile ill-
ness or in a postexposure setting
should consider the probability of
occupational P. falciparum malaria. 
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Nosocomial
Transmission of
Dengue 
To the Editor: Four viruses form
the dengue complex of mosquito-
borne viruses (family Flaviviridae,
genus Flavivirus). Any of these virus-
es can cause dengue fever, an uncom-
plicated febrile illness with rash; how-
ever, these viruses are not transmitted
person to person. The principal mos-
quito vector of these viruses is Aedes
aegypti. These viruses are not known
to exist in Europe; therefore, dengue
virus infections in Europe are seen in
patients returning from dengue-
endemic areas (1). Nosocomial trans-
missions of dengue viruses by needle-
stick have been reported in three
instances (2–4) and by bone marrow
transplant in one instance (5). We
describe the first case of nosocomial
dengue fever diagnosed and treated in
Hungary.
On September 6, 2003, a 46-year-
old physician sought care from the
Department of Infectology, (“Baranya
County Hospital” Pécs, Hungary); he
reported a 4-day history of fever,
headache, malaise, maculopapular
rash, and pharyngitis. He had recently
returned from a trip to Thailand and
recalled having been bitten by a mos-
quito at Bangkok airport 11 days ear-
lier. The patient had no history of ill-
nesses before he left Hungary to go to
Thailand. On examination, laboratory
results indicated leukopenia (3,300
leukocytes/mm3) and mild thrombo-
cytopenia (119,000 platelets/mm3).
Leukopenia is characteristic of
dengue virus and has been associated
with suppression of bone marrow pro-
duction (6). We conducted additional
tests because thrombocytopenia could
have been the first sign of a more
severe form of dengue infection,
dengue hemorrhagic fever, which is
associated with hemorrhagic diathesis
and shock (6). Lymphocytosis and
monocytosis with 26% atypical lym-
phocytes and a high-normal level of
alanine aminotransferase (56 U/L)
were found. The C-reactive protein
level and the erythrocyte sedimenta-
tion rate were normal. Blood smears
for malarial parasites were negative.
Examination of the patient showed
a maculopapular rash, pharyngitis,
and conjunctivitis. Dengue fever was
the clinical diagnosis based on the
patient’s history of a mosquito bite in
a dengue-endemic country, the
patient’s symptoms, and the laborato-
ry results. The patient’s general
condition was relatively good, so we
treated him on an outpatient basis and
recommended that he return for daily
examinations.
On September 7, while collecting a
blood sample from the patient, the
patient’s sister, also a physician, acci-
dentally stuck her finger with the nee-
dle, which was contaminated with the
patient’s blood. Seven days later she
became ill, with fever, headache, dif-
fuse maculopapular rash, myalgia,
cervical lymphadenopathy, and
malaise. Her laboratory tests showed
leukopenia with a normal thrombo-
cyte level, C-reactive protein level,
liver function tests, and erythrocyte
sedimentation rate. On physical
examination, painfully enlarged cervi-
cal lymph nodes and conjunctivitis
were found. No complications were
observed and the disease resolved
within 10 days after onset in both
patients. The female patient had never
traveled to a dengue-endemic region.
Serologic and virologic evidence
confirmed the clinical diagnosis.
Acute-phase serum samples from each
patient were tested for immunoglobu-
lin (Ig) M and IgG antibodies to
dengue viruses by using a commercial
enzyme-linked immunosorbent assay
kit. IgM, but not IgG, antibodies to
dengue viruses were detected in the
serum sample from the male patient 7
days after the onset of his illness; a
convalescent-phase serum sample was
not available for further testing. The
first serum sample was obtained from
the female patient 6 days after onset of
her illness. IgM and IgG antibodies
were not found in that sample. In the
serum sample obtained from the
female patient 12 days after onset,
IgM, but not IgG, antibodies to dengue
viruses were found. Both IgM and IgG
antibodies were found in serum sam-
ples from this patient 3 weeks after
onset of her illness.
Diagnosis was also confirmed by
reverse transcription–polymerase
chain reaction assays of early serum
samples of both patients by using uni-
versal flavivirus primers. Ampli-
fication products were directly
sequenced (GenBank accession no.
AY538627 and AY538628). The
nucleotide sequences were identified
with a BLAST search (http://www.
ncbi.nlm.nih.gov/BLAST/) using the
GenBank database. Highest similarity
was with dengue virus type 2 strain
ThNH76/93, which had been isolated
from a patient in northeast Thailand
during the epidemic season of 1993
(7). The virus- specific nucleotide
sequences detected in the Hungarian
patients showed 98% nucleotide iden-
tity with the corresponding sequences
of the Thai strain.
Viremia and simultaneous anti-
body production has been observed in
several studies of dengue (6,8,9).
Virus isolation is possible in dengue
infections early in the illness, and in
our experience, virus RNA was